<DOC>
	<DOCNO>NCT02597855</DOCNO>
	<brief_summary>To compare short-term effect intravitreal aflibercept injection two subtypes polypoidal choroidal vasculopathy</brief_summary>
	<brief_title>Short-term Efficacy Intravitreal Afilibercept Depending Subtypes Polypoidal Choroidal Vasculopathy : Polypoidal Choroidal Neovascularization Idiopathic Choroidal Vasculopathy</brief_title>
	<detailed_description>The subject classify two subtypes ( type 1 type 2 polypoidal choroidal vasculopathy ) base presence absence feeder drain vessel indocyanine green angiography . All receive intravitreal injection aflibercept ( 2.0 mg ) baseline month 1 , 2 4 .</detailed_description>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>1. symptomatic typical PCV accompany branch vascular network involve subfoveal area 2. sign informed consent ; 3. 6 month followup period enrollment . 1. retinal disease PCV 2. extrafoveal PCV involve subfoveal area 3. massive subretinal hemorrhage block polypoidal lesion ICGA 4. severe medium opacity senile cataract 5. previous history intravitreal injection 6. previous intraocular surgery history except cataract surgery do 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>